SPONSOR

Washington University School of Medicine

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 4, Phase 1, Phase 1, Phase 2, EARLY_Phase 1

Conditions studied: Obesity Skeletal Muscle Brain Connectivity Breast Cancer Cancer of Breast Influenza SARS-CoV-2 (COVID-19) Infection Immune Response of Host Glioblastoma Glioblastoma Multiforme

Washington University School of Medicine is a clinical research sponsor with 36 registered studies on ClinicalTrials.gov, of which 36 are actively recruiting participants. Research covers conditions including Obesity, Skeletal Muscle, Brain Connectivity, Breast Cancer.

The trial portfolio spans Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Washington University School of Medicine

How many clinical trials has Washington University School of Medicine sponsored?

ClinicalMetric currently tracks 36 clinical trials sponsored by Washington University School of Medicine, of which 36 are actively recruiting participants. These trials cover conditions including Obesity, Skeletal Muscle, Brain Connectivity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Washington University School of Medicine research focus on?

Washington University School of Medicine clinical trials span Obesity, Skeletal Muscle, Brain Connectivity, Breast Cancer, Cancer of Breast, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Washington University School of Medicine clinical trial?

To participate in a Washington University School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Washington University School of Medicine trials with current recruitment status updated daily.

Washington University School of Medicine

Frequently Asked Questions — Washington University School of Medicine

Clinical Trials by Washington University School of Medicine

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1

Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients

Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms

Small Extracellular Vesicles and Insulin Action

Migraine in Adolescents

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans

Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain

Cancer Care Companion

A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With Preeclampsia

Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial

Endometriosis Pain

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Role of KATP Channel Loss in Type 2 Diabetes

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Therapeutic RSK1 Targeting in Myeloid Malignancies

PET Imaging CCR2 in Lung Inflammation

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

PET Detection of CCR2 in Human Atherosclerosis

Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheumatica

Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke

Vagus Nerve Stimulation for Myelopathy

Nerve Transfer to Improve Function in High Level Tetraplegia

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Health Information for Persons With Spinal Cord Injury